Non-squamous non-small cell lung cancer
Showing 9976 - 10000 of >10,000
Peripheral T Cell Lymphoma Trial in Chapel Hill, Winston-Salem (ATLCAR.CD30 T cells, Bendamustine, Fludarabine)
Recruiting
- Peripheral T Cell Lymphoma
- ATLCAR.CD30 T cells
- +3 more
-
Chapel Hill, North Carolina
- +1 more
Mar 4, 2022
Actinic Keratoses Trial (Oral Nicotinamide)
Completed
- Actinic Keratoses
- Oral Nicotinamide
- (no location specified)
Apr 20, 2021
TRAQinform Assessment of Immunotherapy Response
Not yet recruiting
- Melanoma
- Non-Interventional
- (no location specified)
Apr 6, 2023
Incidence and Risk Factors of Early Onset Colorectal Cancer
Completed
- Colorectal Neoplasms
- colonoscopy
- (no location specified)
Jan 14, 2022
Hematologic Diseases, Graft Failure, Allogeneic Hematopoietic Stem Cell Transplantation Trial (haplo-SCT with PTCy)
Not yet recruiting
- Hematologic Diseases
- +2 more
- haplo-SCT with PTCy
- (no location specified)
Nov 8, 2021
Tumors, Breast Trial in Worldwide (Lapatinib, Trastuzumab)
Colon Adenocarcinoma, Diarrhea Trial in Aarhus (Antibiotics, Bile Acid Binder)
Completed
- Colon Adenocarcinoma
- Diarrhea
- Antibiotics
- Bile Acid Binder
-
Aarhus, DenmarkDepartment of Hepatology and Gastroenterology, Aarhus University
Aug 31, 2021
Versius Or Laparoscopic Colorectal Cancer and Non-cancer
Recruiting
- Colorectal Disorders
- Laparoscopic Surgeon
- Robotic Arm
-
Milton Keynes, Bucks, United KingdomMilton Keynes University Hospital
Aug 1, 2022
Lung Cancer Trial in Taoyuan (68Ga-FAPI-46)
Not yet recruiting
- Lung Cancer
- 68Ga-FAPI-46
-
Taoyuan, TaiwanDepartment of Nuclear Medicine, Chang Gung Memorial Hospital
Nov 16, 2022
Patients With Bipolar Disorders Trial in Qazvin (Multifaceted intervention, Routine counseling)
Completed
- Patients With Bipolar Disorders
- Multifaceted intervention
- Routine counseling
-
Ahvaz, Iran, Islamic Republic of
- +9 more
Jan 9, 2023
Sickle Cell Disease Trial in Pittsburgh (MitoQ)
Recruiting
- Sickle Cell Disease
- MitoQ
-
Pittsburgh, Pennsylvania
- +4 more
Jan 18, 2022
LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study
Recruiting
- Cancer
- +9 more
-
Edmonton, Alberta, CanadaEdith Pituskin
Nov 30, 2022
Prognosis of AML Patients According to Routinely Used Genetic
Completed
- Acute Myeloid Leukemia
-
Albacete, Spain
- +21 more
Sep 12, 2022
Spine Deformity, Bone Graft; Complications, Adverse Events Trial in Copenhagen (ABM/P-15 bone graft)
Recruiting
- Spine Deformity
- +2 more
- ABM/P-15 bone graft
-
Copenhagen, DenmarkRigshospitalet, Department of Orthopedics, Spine Unit
Feb 15, 2022
HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,
Completed
- HER2-positive Breast Cancer
- +8 more
- Neratinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
NAFLD Trial in Tucson (NAFLD-specific weight loss intervention, Wait-list control)
Not yet recruiting
- NAFLD
- NAFLD-specific weight loss intervention
- Wait-list control
-
Tucson, ArizonaUniversity of Arizona Collaboratory for Metabolic Disease Preven
Oct 7, 2022
Malignant Tumor Trial in Houston (Isopropyl Alcohol, Placebo, Questionnaire Administration)
Not yet recruiting
- Malignant Neoplasm
- Isopropyl Alcohol
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Pulmonary Nodule, Solitary Trial in Brussels (Iriscope)
Recruiting
- Pulmonary Nodule, Solitary
- Iriscope
-
Brussels, BelgiumErasme Hospital
Jun 30, 2022
Quality of Life of Multiple Sclerosis Patients Treated With
Not yet recruiting
- Multiple Sclerosis (MS)
- ofatumumab
- (no location specified)
Nov 27, 2023
B Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia, in Relapse Trial (Decreasing starting times for beginning
Not yet recruiting
- B Acute Lymphoblastic Leukemia
- Acute Lymphoblastic Leukemia, in Relapse
- Decreasing starting times for beginning nivolumab (Time to Event Continual Reassessment Method (TITE-CRM) )
- Nivolumab starting at day -1
- (no location specified)
Apr 4, 2022
Colorectal Adenocarcinoma, Mucinous Adenocarcinoma, Signet Ring Cell Adenocarcinoma Trial in Trondheim, Lørenskog, Oslo
Not yet recruiting
- Colorectal Adenocarcinoma
- +2 more
-
Trondheim, Trondelag, Norway
- +2 more
Aug 15, 2022
Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
Recruiting
- Clear Cell Renal Cell Carcinoma
- No intervention was required for patients or control group in this study
-
Jinan, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Mar 7, 2022
Healthy Trial in Detroit (Patients treated with laser)
Recruiting
- Healthy
- Patients treated with laser
-
Detroit, MichiganHenry Ford Medical Center
Nov 20, 2023
DLBCL, High Grade B-Cell Lymphoma Trial in United States (Venetoclax, Rituximab, Etoposide)
Completed
- Diffuse Large B-Cell Lymphoma
- High Grade B-Cell Lymphoma
- Venetoclax
- +6 more
-
Boston, Massachusetts
- +5 more
Aug 23, 2022
Colorectal Tumors Trial in China (Disitamab vedotin, Tislelizumab)
Recruiting
- Colorectal Neoplasms
- Disitamab vedotin
- Tislelizumab
-
Changzhou, Jiangsu, China
- +5 more
Aug 7, 2022